A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. [electronic resource]
- Nature genetics May 2005
- 526-31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.